Home Current Issue Previous Issues Published Ahead-of-Print Collections For Authors Journal Info
Skip Navigation LinksHome > October 2013 - Volume 32 - Issue 10 > Oseltamivir Treatment for Influenza in Hospitalized Children...
Pediatric Infectious Disease Journal:
doi: 10.1097/INF.0b013e31829be4bc
Original Studies

Oseltamivir Treatment for Influenza in Hospitalized Children Without Underlying Diseases

Bueno, Mercedes MD*; Calvo, Cristina MD, PhD; Méndez-Echevarría, Ana MD, PhD; de José, María Isabel MD, PhD; Santos, Mar MD§; Carrasco, Jaime MD; Tovizi, Miriann MD; Guillén, Sara MD**; de Blas, Ana MD††; Llorente, Marta MD‡‡; Tarrago, Alfredo MD§§; Escosa, Luis MD; Cilleruelo, María José MD, PhD; Tomatis, Cristina MD§; Blazquez, Daniel MD; Otheo, Enrique MD††; Mazagatos, Diana MD*; García-García, Maria Luz MD, PhD

Supplemental Author Material
Collapse Box

Abstract

Aim:

To determine whether the treatment with oseltamivir improves the outcome of children with confirmed influenza infection and no other underlying disease.

Methods:

Multicentric, retrospective study performed in 10 hospitals of Madrid between September 2010 and June 2012. All children admitted to the hospitals with confirmed influenza infections were eligible. Children with risk factors for serious disease and nosocomial influenza infections were excluded. Asthma was not considered an exclusion factor. The study compared patients treated and untreated with oseltamivir. Fever duration, oxygen support, antibiotics administration, length of hospital stay, intensive care admission and bacterial complications were analyzed. To compare variables, χ2 test, Fisher exact test, ANOVA or Mann-Whitney U test were used.

Results:

Two hundred eighty-seven children were included and 93 of them were treated with oseltamivir (32%). There were no significant differences between treated and untreated patients in days of fever after admission (1.7 ± 2; 2.1 ± 2.9, P > 0.05), length of stay (5.2 ± 3.6; 5.5 ± 3.4, P > 0.05), days of hypoxia (1.6 ± 2.3; 2.1 ± 2.9, P > 0.05), diagnosis of bacterial pneumonia (10%; 17%, P > 0.05), intensive care admission (6.5%; 1.5%,P > 0.05) or antibiotic prescription (44%; 51%, P > 0.05). There were no differences when the population was stratified by age (below or over 1 year) or by the presence or absence of asthma.

Conclusions:

There were no proven benefits of treatment with oseltamivir in hospitalized pediatric patients without the underlying diseases or risk factors for developing a serious illness, including those with asthma.

Copyright © 2013 by Lippincott Williams & Wilkins

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.